| Dr Mark Andrew Attiah, MD, MS, MBE, MPH | |
|
170 Manning Dr, Chapel Hill, NC 27514-4221 | |
| (984) 974-6225 | |
| (984) 974-6740 |
| Full Name | Dr Mark Andrew Attiah |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 170 Manning Dr, Chapel Hill, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639566177 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 2023-02173 (North Carolina) | Primary |
| Entity Name | University Of North Carolina At Chapel Hill |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780669200 PECOS PAC ID: 0648181156 Enrollment ID: O20031105000359 |
News Archive
Children born to families where at least one parent has bipolar disorder do not show abnormalities in attachment compared with other children, say Canadian researchers.
Scientists affiliated with VIB and UGent have discovered a mechanism used by the protein A20 to combat inflammation. This could be a very important point of focus in the search for a treatment for autoimmune diseases such as Rheumatoid Arthritis, in which the patient suffers from chronic, uncontrolled inflammation.
ReCor Medical, an emerging medical device company, announced today that its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation has received the CE mark. PARADISE is designed to treat patients with 'resistant' hypertension, a major risk factor for cardiovascular disease.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
Celator Pharmaceuticals today announced data from animal studies demonstrating the superior bone marrow uptake of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, its lead clinical-stage program, as well as the enhanced circulation kinetics and efficacy of its preclinical hydrophobic docetaxel prodrug nanoparticle (HDPN) formulation were presented at the 101st Annual Meeting of the American Association for Cancer Research in Washington, DC (Abstracts 3698 and 5534).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Andrew Attiah, MD, MS, MBE, MPH 170 Manning Dr, Chapel Hill, NC 27514-4221 Ph: (984) 974-6225 | Dr Mark Andrew Attiah, MD, MS, MBE, MPH 170 Manning Dr, Chapel Hill, NC 27514-4221 Ph: (984) 974-6225 |
News Archive
Children born to families where at least one parent has bipolar disorder do not show abnormalities in attachment compared with other children, say Canadian researchers.
Scientists affiliated with VIB and UGent have discovered a mechanism used by the protein A20 to combat inflammation. This could be a very important point of focus in the search for a treatment for autoimmune diseases such as Rheumatoid Arthritis, in which the patient suffers from chronic, uncontrolled inflammation.
ReCor Medical, an emerging medical device company, announced today that its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation has received the CE mark. PARADISE is designed to treat patients with 'resistant' hypertension, a major risk factor for cardiovascular disease.
The U.S. Senate bill's historic expansion of health care coverage cedes control of a much greater portion of the health care system to the medical and insurance industries.
Celator Pharmaceuticals today announced data from animal studies demonstrating the superior bone marrow uptake of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, its lead clinical-stage program, as well as the enhanced circulation kinetics and efficacy of its preclinical hydrophobic docetaxel prodrug nanoparticle (HDPN) formulation were presented at the 101st Annual Meeting of the American Association for Cancer Research in Washington, DC (Abstracts 3698 and 5534).
› Verified 8 days ago
Dr. Vibhor Krishna, M.D., S.M. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-1000 | |
Joshua Evan Loewenstein, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 919-962-2211 | |
Dr. Michael Anthony Galgano, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27514 Phone: 984-974-1000 | |
Deb Ashish Bhowmick, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 170 Manning Dr, Cb 7060, Chapel Hill, NC 27514 Phone: 919-843-6620 | |
Dominique Mario Omar Higgins, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1350 Raleigh Rd, Chapel Hill, NC 27517 Phone: 919-966-7890 | |
Matthew G Ewend, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 Manning Dr, Chapel Hill, NC 27599 Phone: 919-966-8596 Fax: 919-843-5515 |